Windsor Barra Hotel Floorplan
Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
This meeting took place in 2013
Here are the related meetings in 2020:
Transforming Vaccinology (L2)
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Advancing Vaccines in the Genomics Era (T1)
Organizer(s) Bali Pulendran, Chris Wilson and Rino Rappuoli
October 31—November 4, 2013
Windsor Barra Hotel • Rio de Janeiro, Barra da Tijuca, Brazil
Discounted Abstract Deadline: Jun 27, 2013
Abstract Deadline: Jul 30, 2013
Scholarship Deadline: Jun 27, 2013
Discounted Registration Deadline: Aug 29, 2013
Sponsored by FAPERJ – Rio de Janeiro State Agency for Research Development. Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.
Summary of Meeting:
A direct consequence of the Human Genome Project has been the development of so-called “omic” technologies (e.g. genomics, proteomics) that can be used to probe the molecular networks that control biological systems. Such technologies are beginning to be applied to vaccinology to obtain deeper insights about the molecular networks that orchestrate protective immunity induced by vaccination in humans. Such systems biological approaches are enhancing our understanding of the correlates of protective immunities, of the early innate immune signatures of vaccine efficacy, and guiding the rational design of novel and safer vaccines and adjuvants. This meeting will explore the potential of systems biology in vaccine design and development. Participants will include vaccinologists, immunologists, virologists, microbiologists, scientists using systems approaches in other areas of biomedical research, as well as individuals working in industry and health policy who are interested in the potential of genomics in vaccinology. The meeting will address how systems biology has provided insight into the immune response to vaccines, and will also discuss the technical and bioinformatic challenges associated with using systems biology approaches. Researchers will show 'systems vaccinology' approaches can be implemented in vaccine development and clinical trial monitoring.
View Scholarships/Awards
A direct consequence of the Human Genome Project has been the development of so-called “omic” technologies (e.g. genomics, proteomics) that can be used to probe the molecular networks that control biological systems. Such technologies are beginning to be applied to vaccinology to obtain deeper insights about the molecular networks that orchestrate protective immunity induced by vaccination in humans. Such systems biological approaches are enhancing our understanding of the correlates of protective immunities, of the early innate immune signatures of vaccine efficacy, and guiding the rational design of novel and safer vaccines and adjuvants. This meeting will explore the potential of systems biology in vaccine design and development. Participants will include vaccinologists, immunologists, virologists, microbiologists, scientists using systems approaches in other areas of biomedical research, as well as individuals working in industry and health policy who are interested in the potential of genomics in vaccinology. The meeting will address how systems biology has provided insight into the immune response to vaccines, and will also discuss the technical and bioinformatic challenges associated with using systems biology approaches. Researchers will show 'systems vaccinology' approaches can be implemented in vaccine development and clinical trial monitoring.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
THURSDAY, OCTOBER 31
FRIDAY, NOVEMBER 1
SATURDAY, NOVEMBER 2
SUNDAY, NOVEMBER 3
MONDAY, NOVEMBER 4
Conference Program Print | View meeting in 24 hr (international) time
THURSDAY, OCTOBER 31
8:30—11:15 AM
Genetic Dissection of Immunity
Meeting has ended...abstracts no longer viewable online.
*
Rafick-Pierre Sekaly,
Case Western Reserve University, USA
*
J. Christopher Love,
Massachusetts Institute of Technology, USA
Daniel Kastner,
National Institutes of Health, USA
Understanding Human Immunity from Experiments of Nature
Understanding Human Immunity from Experiments of Nature
Thomas R. Hawn,
University of Washington, USA
Genetic Dissection of Innate Immunity during BCG Vaccination
Genetic Dissection of Innate Immunity during BCG Vaccination
Mary Carrington,
NCI, National Institutes of Health, USA
Immunogenetics of Spontaneous Control of HIV
Immunogenetics of Spontaneous Control of HIV
Petter Brodin,
Karolinska Institutet, Sweden
Short Talk: Separating Genetic and Environmental Influences in the Human Immune System
Short Talk: Separating Genetic and Environmental Influences in the Human Immune System
Tomer Hertz,
Ben-Gurion University of the Negev, Israel
Short Talk: HLA A*02 Modifies Vaccine Efficacy in the RV144 Thai Trial
Short Talk: HLA A*02 Modifies Vaccine Efficacy in the RV144 Thai Trial
11:15 AM—12:15 PM
Keynote Address
Meeting has ended...abstracts no longer viewable online.
*
Chris Wilson,
Bill & Melinda Gates Foundation, USA
Rino Rappuoli,
GlaxoSmithKline Vaccines, Italy
Designing Vaccines for the 21st Century Society
Designing Vaccines for the 21st Century Society
2:30—4:00 PM
Workshop 1: Immunity to Infections
*
Andrew B. Ward,
The Scripps Research Institute, USA
*
Tomer Hertz,
Ben-Gurion University of the Negev, Israel
Elizabeth Ernestina Godoy-Lozano,
Instituto Nacional de Salud Pública, Mexico
B Cells Repertoire Analysis in Patients with Dengue Fever and Dengue Hemorrhagic Fever
B Cells Repertoire Analysis in Patients with Dengue Fever and Dengue Hemorrhagic Fever
Duane R. Wesemann,
Harvard Medical School, USA
Microbial Colonization Influences Primary Immunoglobulin Diversification in the Gut Lamina Propria
Microbial Colonization Influences Primary Immunoglobulin Diversification in the Gut Lamina Propria
Shaikh Meshbahuddin Ahmad,
International Centre for Diarrhoeal Disease Research (icddr,b)
Vitamin A Supplementation during Pregnancy Interfere Passive Influenza Antibody Transfer to Infants
Vitamin A Supplementation during Pregnancy Interfere Passive Influenza Antibody Transfer to Infants
Juan C. Alvarez,
Universidad de Antioquia, Colombia
Using Reverse Vaccinology to Identify Antigen Candidates for a Molecularly-Defined Vaccine Against Leishmania (Viannia) panamensis
Using Reverse Vaccinology to Identify Antigen Candidates for a Molecularly-Defined Vaccine Against Leishmania (Viannia) panamensis
Arman Bashirova,
SAIC-Frederick, USA
LILRB2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection
LILRB2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection
5:30—7:30 PM
Genomics of T Cell Responses to Vaccination
Meeting has ended...abstracts no longer viewable online.
*
Antonio Lanzavecchia,
Institute for Research in Biomedicine, Switzerland
*
Scott D. Boyd,
Stanford University, USA
Rafi Ahmed,
Emory University School of Medicine, USA
Vaccination and Immune Memory
Vaccination and Immune Memory
Rafick-Pierre Sekaly,
Case Western Reserve University, USA
Inflammation, a Driver of the Immune Response to Vaccines
Inflammation, a Driver of the Immune Response to Vaccines
J. Christopher Love,
Massachusetts Institute of Technology, USA
Microtools for Probing T Cell Responses
Microtools for Probing T Cell Responses
Arno C. Andeweg,
Erasmus MC, Netherlands
Short Talk: Dendritic Cell Vaccination of HIV-Infected Individuals Results in a Major and Sustained Shift of the Blood Transcriptome
Short Talk: Dendritic Cell Vaccination of HIV-Infected Individuals Results in a Major and Sustained Shift of the Blood Transcriptome
8:30—11:30 AM
Systems Biological Approaches to Vaccination
Meeting has ended...abstracts no longer viewable online.
*
Ofer Levy,
Boston Children's Hospital, USA
*
Jorg J. Goronzy,
Stanford University School of Medicine, USA
Bali Pulendran,
Stanford University School of Medicine, USA
Systems Vaccinology
Systems Vaccinology
Alan Aderem,
Center for Infectious Disease Research, USA
Systems Vaccinology: Using the Tools of Systems Biology to Enable Rational Vaccine Design
Systems Vaccinology: Using the Tools of Systems Biology to Enable Rational Vaccine Design
Mark M. Davis,
Stanford University School of Medicine, USA
New Approaches and Analyses of Influenza Vaccination
New Approaches and Analyses of Influenza Vaccination
Danilo R. Casimiro,
Aeras, USA
Genome-Wide Transcriptional Analyses for Biomarker Discovery in Vaccine R&D
Genome-Wide Transcriptional Analyses for Biomarker Discovery in Vaccine R&D
Junichi Ito,
National Institute of Biomedical Innovation (NIBIO)
Short Talk: A Comprehensive Analysis of miRNA Expression Profile in Human Serum Collected from Type-A Influenza Vaccine Clinical Trial
Short Talk: A Comprehensive Analysis of miRNA Expression Profile in Human Serum Collected from Type-A Influenza Vaccine Clinical Trial
2:30—4:30 PM
Workshop 2: Immunity to Vaccines
*
Petter Brodin,
Karolinska Institutet, Sweden
*
Hana Golding,
US Food and Drug Administration, USA
Helder I. Nakaya,
Emory University, USA
Large Scale Network Modeling Reveals Distinctive Transcriptomic Programs in Vaccine Antibody Response
Large Scale Network Modeling Reveals Distinctive Transcriptomic Programs in Vaccine Antibody Response
Luis Miguel Franco,
National Institutes of Health, USA
Integrative Genomic Analysis of the Human Immune Response to Influenza Vaccination
Integrative Genomic Analysis of the Human Immune Response to Influenza Vaccination
Katie L. Flanagan,
Monash University, Australia
Temporal Heterogeneity in the Systemic Immune Pathway Response to Measles Vaccination
Temporal Heterogeneity in the Systemic Immune Pathway Response to Measles Vaccination
Magali Matsumiya,
University of Oxford, UK
The Immune Response to MVA85A in Infants
The Immune Response to MVA85A in Infants
Gabriel C. Wu,
University of Texas, Austin, USA
A Proteomic Analysis of the Human Antibody Response to the Seasonal Trivalent Influenza Vaccine
A Proteomic Analysis of the Human Antibody Response to the Seasonal Trivalent Influenza Vaccine
Anwar Hashem,
King Abdulaziz University, Saudi Arabia
A Universal Influenza Vaccine Based on the HA2 Subunit of the Viral Hemaggultinin
A Universal Influenza Vaccine Based on the HA2 Subunit of the Viral Hemaggultinin
Sylvie Bertholet,
Novartis Vaccines and Diagnostics, Italy
Reinventing the Gene Vaccine: SAM® Vaccine Against Influenza
Reinventing the Gene Vaccine: SAM® Vaccine Against Influenza
5:00—7:15 PM
Genomics of Antibody Responses to Vaccination
Meeting has ended...abstracts no longer viewable online.
*
Mark M. Davis,
Stanford University School of Medicine, USA
*
Scott Presnell,
Benaroya Research Institute, USA
Scott D. Boyd,
Stanford University, USA
Deep Sequencing of Human Antibody Repertoires during Influenza Vaccination Shows Convergent Antibody Rearrangements and Seroconversion Signatures
Deep Sequencing of Human Antibody Repertoires during Influenza Vaccination Shows Convergent Antibody Rearrangements and Seroconversion Signatures
Antonio Lanzavecchia,
Institute for Research in Biomedicine, Switzerland
Dissecting the Antibody Response to Pathogens and Self Antigens
Dissecting the Antibody Response to Pathogens and Self Antigens
Hana Golding,
US Food and Drug Administration, USA
Expanding the Antibody Repertoire and Avidity with Adjuvants
Expanding the Antibody Repertoire and Avidity with Adjuvants
Brandon DeKosky,
University of Kansas, USA
Short Talk: Vaccine Response Analysis by High-Throughput Sequencing of the Paired Human Immunoglobulin Heavy and Light Chain Repertoire
Short Talk: Vaccine Response Analysis by High-Throughput Sequencing of the Paired Human Immunoglobulin Heavy and Light Chain Repertoire
Frances Eun-Hyung Lee,
Emory University, USA
Short Talk: Heterogeneity of Antibody Secreting Cell Subsets in Blood after Vaccination and Bone Marrow in Healthy Adults: Identification of Human Long-Lived Plasma Cells
Short Talk: Heterogeneity of Antibody Secreting Cell Subsets in Blood after Vaccination and Bone Marrow in Healthy Adults: Identification of Human Long-Lived Plasma Cells
8:30—11:30 AM
Genomic and Structural Approaches to Antigen and Adjuvant Discovery, Design and Validation
Meeting has ended...abstracts no longer viewable online.
*
Bonnie B. Blomberg,
University of Miami School of Medicine, USA
*
Danilo R. Casimiro,
Aeras, USA
Peter D. Kwong,
NIAID, National Institutes of Health, USA
Structural Vaccinology
Structural Vaccinology
Ian A. Wilson,
The Scripps Research Institute, USA
Structural Insights into HIV and Influenza Antigen Design
Structural Insights into HIV and Influenza Antigen Design
Rhea N. Coler,
Infectious Disease Research Institute, USA
Reverse Vaccinology for TB Antigen Discovery
Reverse Vaccinology for TB Antigen Discovery
Scott Presnell,
Benaroya Research Institute, USA
Module Repertoire Analysis Applied to Vaccine Response Studies
Module Repertoire Analysis Applied to Vaccine Response Studies
Charalambos (Harry) D. Partidos,
Takeda Vaccines, Inc., USA
Short Talk: Dissecting the Immune Responses to DENVax, a Novel Tetravalent Dengue Vaccine
Short Talk: Dissecting the Immune Responses to DENVax, a Novel Tetravalent Dengue Vaccine
5:00—7:00 PM
Lessons to Be Learned from Other Fields
Meeting has ended...abstracts no longer viewable online.
*
Chris Wilson,
Bill & Melinda Gates Foundation, USA
*
Rhea N. Coler,
Infectious Disease Research Institute, USA
Mauro Martins Teixeira,
Universidade Federal de Minas Gerais, Brazil
Mechanisms of Resistance and Disease in Dengue Infection
Mechanisms of Resistance and Disease in Dengue Infection
Ricardo T. Gazzinelli,
Fundação Oswaldo Cruz-CPqRR, Brazil
Exploring Multi-Copy Gene Families in the Development of Trypanosoma cruzi as a Live Attenuated Vaccine Vector
Exploring Multi-Copy Gene Families in the Development of Trypanosoma cruzi as a Live Attenuated Vaccine Vector
Adrian V. S. Hill,
Jenner Institute, University of Oxford, UK
Can Genes Help Design New Vaccines?
Can Genes Help Design New Vaccines?
Andrew B. Ward,
The Scripps Research Institute, USA
Short Talk: Cryo-EM Studies of HIV-1 Env
Short Talk: Cryo-EM Studies of HIV-1 Env
8:30—11:30 AM
Immunology of Vaccination in the Young and Elderly
Meeting has ended...abstracts no longer viewable online.
*
Rino Rappuoli,
GlaxoSmithKline Vaccines, Italy
*
Robert L. Coffman,
Dynavax Technologies, USA
Jorg J. Goronzy,
Stanford University School of Medicine, USA
Dissecting the T Cell Response in the Elderly
Dissecting the T Cell Response in the Elderly
Bonnie B. Blomberg,
University of Miami School of Medicine, USA
Biomarkers of Vaccine Efficacy in the Elderly
Biomarkers of Vaccine Efficacy in the Elderly
Ofer Levy,
Boston Children's Hospital, USA
Microphysiologic Modeling of Immune Responses to Inform Age-Specific Vaccine Development
Microphysiologic Modeling of Immune Responses to Inform Age-Specific Vaccine Development
Andrew J. Pollard,
University of Oxford, UK
Transcriptional Signatures of Adjuvanted Influenza Vaccines in Children
Transcriptional Signatures of Adjuvanted Influenza Vaccines in Children
Thomas J. Scriba,
University of Cape Town, South Africa
Short Talk: Correlates of Progression from Mycobacterium tuberculosis Infection to Tuberculosis Disease in Adolescents
Short Talk: Correlates of Progression from Mycobacterium tuberculosis Infection to Tuberculosis Disease in Adolescents
12:30—2:30 PM
Translation of Immunological Concepts to the Clinic
Meeting has ended...abstracts no longer viewable online.
*
Ian A. Wilson,
The Scripps Research Institute, USA
*
Andrew J. Pollard,
University of Oxford, UK
Lynda G. Tussey,
VaxInnate Corporation, USA
Modifying the Agonist Properties of Flagellin to Improve Vaccine Performance
Modifying the Agonist Properties of Flagellin to Improve Vaccine Performance
Ennio De Gregorio,
GlaxoSmithKline Vaccines, Italy
Vaccine Adjuvants: From Empiricism to Rational Design
Vaccine Adjuvants: From Empiricism to Rational Design
Robert L. Coffman,
Dynavax Technologies, USA
Advancing TLR9 Ligands as Vaccine Adjuvants in Humans
Advancing TLR9 Ligands as Vaccine Adjuvants in Humans
Wayne C. Koff,
Human Vaccines Project, USA
Short Talk: The Case for a Human Vaccines Project to Accelerate Global Disease Prevention
Short Talk: The Case for a Human Vaccines Project to Accelerate Global Disease Prevention
*Session Chair †Invited, not yet responded.
Keystone Symposia thanks our Sponsors for generously supporting this meeting:
|
FAPERJ – Rio de Janeiro State Agency for Research Development |
We gratefully acknowledge the generous grant for this conference provided by:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Corporate Relations, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org, Phone:+1 970-262-1179 |
